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490Objective: Preoperative weight loss might increase the risk of postoperative morbidity and mortality after
esophagectomy for cancer.We hypothesized that patients with esophageal cancer with>10%weight loss during
the 3 months before their diagnosis would be at an increased risk of postoperative complications, have a longer
length of stay, and have worse overall survival.
Methods: In the present hospital-based cohort study, all patients who had undergone surgery for esophageal can-
cer in 1990 to 2010 at the Erasmus UniversityMedical Center Rotterdamwere included.Weight loss was defined
as ‘‘no, or limited’’ (10%) or ‘‘severe’’ (>10%). Logistic regression analysis was used to estimate the relative
risk of complications, expressed as odds ratios (ORs) with 95% confidence intervals (CIs). Hazard ratios were
calculated to assess the length of hospital stay and survival. The risk estimates were adjusted for potential
confounding factors.
Results: Of 922 included patients, 155 (17%) had experienced severe weight loss. These patients had no
increased risk of early surgical, early nonsurgical, or late surgical complications (OR, 0.83 and 95% CI,
0.54-1.24; OR, 0.90 and 95% CI, 0.63-1.30; OR, 1.14 and 95% CI, 0.79-1.66, respectively) and had no
increased length of stay (hazard ratio, 1.09; 95% CI, 0.89-1.35). Preoperative weight loss was followed by
increased 5-year mortality (hazard ratio, 1.34; 95% CI, 1.02-1.74).
Conclusions: A>10% preoperative weight loss was followed by decreased 5-year survival after esophageal
cancer surgery but no increased risk of postoperative complications. (J Thorac Cardiovasc Surg 2014;147:490-5)Most patients with esophageal cancer will experience
dysphagia, leading to reduced food intake.1 Furthermore,
increased energy consumption caused by systemic inflam-
mation induced by the tumor enhances weight loss.2 This
systemic inflammation results from local effects of the
tumor directly or a secondary host response to tumor tis-
sue necrosis and hypoxia, which stimulates secretion of
interleukins (interleukin-1 and -6), tumor necrosis fac-
tor-a, interferons (interferon-g), hematopoietic growth
factors, and acute phase proteins.3,4 Thus, unintentional
and substantial (>10%-15%) weight loss will occur in
approximately 80% of all patients with esophageal
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The Journal of Thoracic and Cardiovascular SurgMalnutrition seems to be associated with increased early
postoperative morbidity and mortality and reduced overall
survival after major gastrointestinal surgery in general.4,6-8
Two studies of patients with esophageal cancer specifically
did not detect any association between the body mass index
(BMI), as a surrogate for nutritional status, and morbidity
after esophagectomy.9,10 However, patients with esophageal
cancer with a high BMI are often malnourished owing to
substantial weight loss within a relatively short period.11
We tested the hypotheses that patientswith esophageal cancer
with>10% unintentional weight loss during the 3 months
before the diagnosis are at increased risk of postoperative
complications, have a longer length of stay, and have a worse
overall survival.METHODS
Patients
The patients were identified from a cohort of patients with cancer of the
esophagus or gastroesophageal junction treated at the Erasmus Medical
Center, University Medical Center Rotterdam (Rotterdam, The
Netherlands). Information on patient demographics, clinical and patho-
logic characteristics, details on treatment, surgical procedure, and postop-
erative course was prospectively collected by a specialized data manager.
All patients diagnosed with invasive squamous cell carcinoma or adenocar-
cinoma of the esophagus who had undergone surgical tumor resection with
or without preoperative chemotherapy or radiotherapy, from May 1, 1990
to October 29, 2010 were included.ery c January 2014
Abbreviations and Acronyms
BMI ¼ body mass index
CI ¼ confidence interval
HR ¼ hazard ratio
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The patients underwent an open transhiatal or transthoracic approach.
With the transhiatal approach, the distal esophagus and all periesophageal
tissue, including the lymph nodes and bilateral parietal pleura, was
dissected under direct visualization through a widened hiatus of the dia-
phragm up to the level of the inferior pulmonary vein. All lymph nodes
at the origin of the celiac axis were routinely dissected and included in
the specimen. A gastric tube was typically created to replace the resected
specimen. After mobilization of the cervical esophagus trough, a left-
sided neck incision, the intrathoracic esophagus was bluntly resected
from the neck to the abdomen using a vein stripper. An esophagogastros-
tomywas created between the proximal esophageal remnant and the gastric
conduit using either a circular stapler or a hand-sewn technique.
Patients who underwent the transthoracic approach (3-stage McKeown)
received a right-sided posterolateral thoracotomy in which the esophagus,
periesophageal tissue in the posterior mediastinum, the thoracic duct, and
azygos vein were dissected. Subcarinal lymph nodes were routinely
included in the specimen. Right-sided paratracheal and aorta-pulmonary
window lymph nodes were dissected in all cases of squamous cell carci-
noma and cases of adenocarcinoma in which macroscopically suspicious
tumor involvement was found. The subsequent abdominal and cervical
phasewas similar to that of the transhiatal approach.12 All patients received
a feeding jejunostomy or nasojejunal catheter for perioperative enteral
feeding.
Study Exposure
The exposure was defined as unintentional weight loss during the 3
months before diagnosis and categorized as ‘‘no or limited (10%)’’ or
‘‘severe (>10%)’’ weight loss. At the first visit to the outpatient clinic,
the patients estimated their weight for the 3 months before their first visit.
This weight was considered their baseline weight. All reported weight loss
was considered unintentional. The patients were weighed at the same visit
to the outpatient clinic (actual weight), and the percentage of weight loss in
the 3 months before the diagnosis was calculated by subtracting the base-
line weight from the actual weight, dividing this difference by the baseline
weight, andmultiplying by 100. No uniform consensus has been reached on
the definition of malnutrition in relation toweight loss, but it has often been
referred to as>10% to 15% weight loss within 6 months,13>5% in 3
months,14 or >10% within 6 months15 before surgery. The choice of
10% weight loss as a cutoff was predefined and chosen on the basis of
earlier studies, in which such weight loss was found to be associated
with an increased risk of postoperative complications after major abdom-
inal surgery.15
Study Outcomes
We included 3 study outcomes: (1) postoperative complications,
(2) length of hospital stay, and (3) overall survival. Postoperative compli-
cations were categorized into early surgical complications, early nonsur-
gical complications, and late surgical complications. Early complications
were those that occurred within 30 days after primary esophagectomy.
Late complications were defined as those occurring>30 days after the pri-
mary surgery. Early surgical complications included anastomotic leak,
recurrent laryngeal nerve paresis or paralysis, bleeding, ileus, severe chyle
leakage, leakage of the feeding jejunostomy, gastroparesis for>10 daysThe Journal of Thoracic and Caafter surgery, wound infection, and necrosis of the substitute. Early non-
surgical complications were categorized as infectious complications
(includingpneumonia, sepsis, and urinary tract infection) and noninfectious
complications (including acute respiratory distress syndrome, myocardial
infarction, and thromboembolic events). Late surgical complications were
those occurring>30 days after surgery and included anastomotic stenosis
requiring dilatation, pyloric stenosis requiring intervention, intercostal
neuralgia, ileus, excessiveweight loss, and cachexia. The length of hospital
stay was defined as the number of days in the hospital since the date of the
primary operation.
Overall survival was calculated from the date of esophagectomy until
death or the end of the follow-up period, which was up to 5 years postop-
eratively. The patients were seen in the outpatient clinic every 3 months
during the first postoperative year, every 6 months the second year, and
yearly thereafter until 5 years after surgery. Imaging was not routinely per-
formed during the follow-up visits but only for those patients presenting
with clinical signs of recurrence.
Statistical Analysis
The relative risks of weight loss in relation to complications were calcu-
lated using logistic regression analysis and are expressed as odds ratios
(ORs), with the 95% confidence intervals (CIs). In a multivariate model,
the OR of complications in relation to weight loss was adjusted for poten-
tial confounding by age (continuous variable), gender, tumor stage (histo-
pathologic stage, classified according to the 6th version of the Union for
International Cancer Control-pTNM classification and categorized into
4 groups: 0-I, II, III, and IV), comorbidity (including cardiovascular, respi-
ratory, and neurologic disease, diabetes mellitus, and psychiatric disorders
and categorized as 0 or 1), and neoadjuvant chemotherapy and/or radio-
therapy (yes or no).
The chi-square test and t test were used to examine the association
between the baseline clinical characteristics and weight loss.
To assess whether the BMI was associated with weight loss and could
potentially influence the results, aWald test was used to test the interactions
between the BMI and weight loss. The BMI was defined as the weight
before surgery divided by the patient’s height in meters squared (kg/m2)
and categorized into 3 groups:<25, 25-29, 30 kg/m2.
The Kaplan-Meier method was used to illustrate the hospital admission
time and overall survival in the comparison groups, and the log-rank test
was used to analyze the statistically significant differences between the
curves.
Cox regression analysis was used to calculate the hazard ratios (HRs),
with the 95% CIs, regarding hospital admission time and overall survival.
In a multivariate model, the HRs of differences in admission time and over-
all survival were adjusted for potential confounding by age, gender, tumor
stage, comorbidity, and use of neoadjuvant treatment. P<.05 was consid-
ered statistically significant.
All analyses were performed using Stata, version 11, for Mac (Stata-
Corp, Inc, College Station, Tex).RESULTS
Patient Characteristics
During the study period, 1271 patients with cancer of
the esophagus or gastroesophageal junction were consid-
ered for surgical resection at the Erasmus Medical Center
University Medical Center Rotterdam. Exclusions were
made because the primary plan (surgical tumor resection)
was not pursued (235 patients [18%]), different histologic
type (17 patients [1.3%]), and missing information of
explanatory variables (67 patients [5.2%]). Of the 922 re-
maining patients (73%), 155 (17%) had lost>10% ofrdiovascular Surgery c Volume 147, Number 1 491
TABLE 1. Patient characteristics (n ¼ 922)
Variable Total
Weight
loss  10%
Weight
loss>10%
P
value
Total 922 (100) 767 (83) 155 (17) NS
Age (y) 63  10 62  10 60  10 .0348
Gender
Male 712 (77) 609 (79) 103 (66) .0005
Female 210 (23) 158 (21) 52 (34) NS
BMI* (kg/m2)
<25 419 (45) 324 (48) 95 (75) .001
25-29 285 (31) 260 (39) 25 (20) NS
30 95 (10) 88 (13) 7 (6) NS
Missing 89 (13) 73 (13) 16 (15) NS
Comorbidityy
None 421 (46) 360 (47) 61 (40) NS
1 501 (54) 407 (53) 94 (61) NS
Neoadjuvant treatment
No 721 (79) 601 (78) 120 (77) NS
Yes 201 (22) 166 (22) 35 (23) NS
Histologic type
Squamous cell 263 (25) 223 (29) 60 (37) NS
Adenocarcinoma 622 (69) 527 (69) 95 (61) NS
Adenocarcinoma in
Barrett’s epithelium
17 (2) 17 (2) 0 (0) NS
Tumor stagez
0-I 173 (19) 162 (21) 11 (7) NS
II 257 (28) 212 (28) 45 (29) NS
III 432 (47) 342 (45) 90 (58) .001
IV 10 (1) 6 (1) 4 (30) NS
Unknown 49 (7) 45 (7.8) 4 (4) NS
Surgical approach
Transhiatal 722 (79) 610 (80) 112 (73) NS
Transthoracic 169 (18) 135 (18) 34 (22) NS
Otherx 28 (3) 20 (3) 8 (5) NS
Data presented as mean  standard deviation or n (%). NS, Nonsignificant; BMI,
body mass index. *BMI was determined from weight before surgery. yComorbidities
included cardiovascular, respiratory, and neurologic disease, diabetes mellitus, and
psychiatric disorders. zTumor stage after pathologic examination according to the
6th revision of the Union for International Cancer Control-TNM classification.
xDefined as left-sided thoracolaparotomy or transthoracic esophagectomy with cervi-
cal anastomosis.
TABLE 2. Postoperative course after esophagectomy for cancer
(n ¼ 922)
Variable Total
Weight
loss  10%
Weight
loss>10%
Length of hospital stay (d)* 22  21 22  21 20  15
Postoperative mortalityy 71 (8) 55 (7.1) 16 (10)
Early surgical complicationsz
None 674 (73.0) 556 (60.0) 118 (12.8)
1 249 (27.0) 212 (23.0) 37 (4.0)
Early nonsurgical complicationsx
None 450 (48.8) 370 (40.1) 80 (8.7)
1 473 (51.3) 398 (43.0) 75 (8.1)
Late surgical complicationsjj
None 570 (63) 468 (52.8) 92 (10.4)
1 327 (36.9) 267 (30.1) 60 (6.8)
Data presented as mean  standard deviation or n (%). *Admission time was calcu-
lated from the day of surgery until discharge. yDefined as death within 90 days after
surgery. zDefined as complications occurring within 30 days after the initial surgery,
including anastomotic leak, recurrent laryngeal nerve paresis or paralysis, bleeding,
small bowel obstruction, chyle leakage, leakage of the feeding tube, gastroparesis for
>10 days after surgery, wound infection, or necrosis of the substitute for which a re-
operation was required. xDefined as acute respiratory distress syndrome and throm-
boembolic events. jjDefined as complications occurring>30 days after the initial
surgery, including anastomotic stenosis (requiring dilatation or therapy), pyloric ste-
nosis, intercostal neuralgia, ileus, weight loss, and cachexia.
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Mtheir usual weight in the 3 months before diagnosis and
were thus classified as exposed. The 336 patients (26.4%)
who had undergone nonradical resection (ie, R1 and R2
resection) were excluded from the long-term survival ana-
lyses but were included in the short-term outcome analyses
(eg, length of hospital stay, postoperative mortality, and
early surgical, nonsurgical, and long-term complications).
The association between the baseline characteristics and
weight loss were assessed using chi-square analyses.
Male gender, higher tumor stage, and a low BMI were
associated with the>10% weight loss (P< .05 for all).
Moreover, the patients with >10% weight loss were
younger (P<.05, t test). The patient and tumor character-
istics of the exposed and nonexposed patients are listed in
Table 1.492 The Journal of Thoracic and Cardiovascular SurgComplications
A total of 249patients (27%) developed a surgical compli-
cation within 30 days after surgery. In general, no increased
risk of such early surgical complications was found between
the patients with andwithout weight loss (adjustedOR, 0.83;
95% CI, 0.54-1.24). No statistically significant increased
risk of anastomotic leak was found (adjusted OR, 0.87;
95% CI, 0.46-1.64), wound infections (adjusted OR, 1.1;
95% CI, 0.47-2.45), or necrosis of the substitute (adjusted
OR, 1.1; 95% CI 0.34-13.20; Table 2).
A total of 472 patients (51%) developed an early nonsur-
gical complication. No increased risk of such complications
was found between the exposed and nonexposed groups
(adjusted OR, 0.90; 95% CI, 0.63-1.30; Table 2).
Late surgical complications were diagnosed in 327 pa-
tients (35%). No increased risk was identified in patients
with weight loss (Table 2).
Length of Hospital Stay
The mean admission time was 22  20.9 days and 20 
15.3 days for patients with and without weight loss, respec-
tively (Table 1). The Kaplan-Meier curve comparing the
admission time is shown in Figure 1. No difference was
found in the admission time for patients with and without
weight loss (log-rank, 0.6194). In the adjusted analysis,
weight loss did not influence the length of stay (HR, 1.06;
95% CI, 0.85-1.33; Table 3).
Survival
The Kaplan-Meier curve comparing patients with and
without weight loss regarding overall survival for up toery c January 2014
p value=0.6194 (Log−rank test)
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FIGURE 1. Length of hospital stay in days after esophagectomy in 922
patients with and without weight loss 3 months before the esophageal can-
cer diagnosis.
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FIGURE 2. Overall 5-year survival of 681 patients with and without
weight loss 3 months before the esophageal cancer diagnosis who under-
went esophagectomy.
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worse overall survival for patients with weight loss
(P<.0001; Figure 2). After adjustment for potential con-
founders, the patients with weight loss had slightly
increased mortality within 5 years after surgery (adjusted
HR, 1.34; 95% CI, 1.02-1.74) (Table 4).
Interactions
No statistically significant interactions were found be-
tween the BMI and preoperative weight loss regardingTABLE 3. Risk of complications after esophagectomy in association
with weight loss 3 months before esophageal cancer diagnosis
Complications n (%)
Weight
loss  10%
Weight
loss>10%
Early surgical*
All surgical 249 (27.0) 1.0 (Reference) 0.83 (0.54-1.24)
Anastomotic leak 89 (10) 1.0 (Reference) 0.87 (0.46-1.64)
Wound infection 41 (4) 1.0 (Reference) 1.1 (0.47-2.45)
Necrosis of the substitute 25 (3) 1.0 (Reference) 1.1 (0.34-3.20)
Other surgicaly 108 (12) 1.0 (Reference) 0.9 (0.52-1.61)
Early nonsurgical
All nonsurgical 472 (51) 1.0 (Reference) 0.90 (0.63-1.30)
Infectiousz 336 (36) 1.0 (Reference) 1.20 (0.77-1.91)
Noninfectiousx 76 (8) 1.0 (Reference) 0.47 (0.17-1.23)
Late surgicaljj
All late surgical 327 (35) 1.0 (Reference) 1.14 (0.79-1.66)
Anastomotic stenosis 245 (27) 1.0 (Reference) 1.10 (0.68-1.81)
Data presented as number of complications (%) or odds ratio (95% confidence inter-
val). *Defined as complications occurring within 30 days after the initial surgery.
yDefined as anastomotic leak, recurrent laryngeal nerve paresis or paralysis, bleeding,
small bowel obstruction, chyle leakage, leakage of the feeding tube, gastroparesis for
>10 days after surgery, wound infection, and necrosis of the substitute for which a
reoperation was required. zDefined as pneumonia, sepsis, and urinary tract infection
requiring treatment. xDefined as acute respiratory distress syndrome and thromboem-
bolic events occurring within 30 days after the initial surgery. jjDefined as complica-
tions occurring>30 days after the initial surgery, including anastomotic stenosis
(requiring dilatation or therapy), pyloric stenosis, intercostal neuralgia, ileus, weight
loss, and cachexia.
The Journal of Thoracic and Cacomplications (Wald chi-square, 3.0; P ¼ .271), length of
hospital stay (Wald chi-square, 2.5; P ¼ .280), overall
survival (Wald chi-square, 0.3; P ¼ .835), or disease-free
survival (Wald chi-square, 1.0; P ¼ .603).P
MDISCUSSION
The results of the present study indicate that uninten-
tional preoperative weight loss of10% before esophageal
cancer resection is followed by worse overall 5-year sur-
vival but does not influence the risk of postoperative com-
plications or length of hospital stay.
Among the strengths of the present study were the pro-
spective collection of data in a predefined study form, which
decreased the risk of systematic errors resulting from
misclassification. Furthermore, an independent data man-
ager, not involved in care of the patients, collected the clin-
ical information, which further decreased the risk of biased
data collection. Information about important clinical vari-
ables was available, which facilitated adjustment for poten-
tial confounding. Among the weaknesses of the study was
the risk of residual confounding, which is an issue in obser-
vational studies owing to the lack of randomization.
Another potential weakness of the study was patient selec-
tion, because only patients whowerewell enough to undergo
surgery were included. This might imply that patients who
were severely malnourished, were severely overweight, or
had many concurrent diseases were considered too frail toTABLE 4. Effect of preoperative>10%weight loss before esophageal
cancer diagnosis on overall and disease-free survival and hospital
duration after esophagectomy
Variable HR 95% CI P value
Overall 5-y survival* 1.34 1.02-1.74 .03
Length of hospital stay 1.09 0.89-1.35 .41
HR, Hazard ratio; CI, confidence interval. *Occurrence of an event means death.
rdiovascular Surgery c Volume 147, Number 1 493
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Mundergo surgery. Moreover, the recall of the patients’ esti-
mated weight 3 months before the diagnosis might have
increased the likelihood of misclassification. However, a
recent study has suggested that a patient’s estimated weight
is as accurate as ameasuredweight at the outpatient clinic.16
Another potential weakness was the lack of objective mea-
surements of malnutrition (eg, serum albumin and C-reac-
tive protein levels). We also did not have information on
interventions to prevent weight loss after the diagnosis of
esophageal cancer. Moreover, no detailed information was
available on the patients’ nutritional intake, which could
be of concern, because patients often adjust their diet after
having developed eating difficulties before seeking medical
attention.2 When adjusting for confounding factors, the tu-
mor stage was classified according to the 6th version of
the Union for International Cancer Control-TNM classifica-
tion.We realize that this classification has some limitations
compared with the 7th version of the TNM classification.
However, in the present cohort, not all the information
required for staging using the 7th edition (eg, number of
resected lymph nodes) was available. Thus, we were un-
able to analyze the results using the 7th revised staging
system. Also, we used the histopathologic TNM stage
and not the clinical TNM stage, which has some limita-
tions. The clinical TNM stage does not take into account
downstaging after preoperative chemoradiotherapy. How-
ever, only the vast minority of our cohort underwent preop-
erative chemoradiotherapy.
It has generally been believed that severe weight loss
before surgery in patients with cancer increases the risk of
infectious and noninfectious complications. Hence, the
optimization of nutritional status by parenteral and enteral
feeding aimed at reducing postoperative morbidity and
mortality has frequently been deployed. The results of the
present study, however, have shown that patients with
esophageal cancer who had lost>10% body weight in the
3 months before the diagnosis were not at an increased
risk of postoperative complications.
Increased overall 5-year mortality was found among
patients who had lost>10% weight before esophageal can-
cer surgery. This is a novel finding specifically regarding
esophageal cancer surgery, but reduced survival has been
described for general abdominal surgery.4,17,18 Although
the mechanism behind this is unclear, reduced immune
function in malnourished patients might be associated
with a reduced chance of survival.4
The results of the present study pose the question of
whether it is useful to halt additional weight loss after diag-
nosis and correct weight loss before patients undergo sur-
gery, after some interval of delay. Some evidence has
shown that patients with an increased risk of severe malnu-
trition, such as severe weight loss (>10%), a low BMI
(<18 kg/m2), or increased inflammatory parameters, might
benefit from nutritional support and the involvement of494 The Journal of Thoracic and Cardiovascular Surgdieticians before surgery.19 However, patients who did not
have severe weight loss did not seem to benefit strongly
from preoperative nutritional support.19
Earlier studies have suggested that the BMI per se is not
associated with a risk of postoperative complications or sur-
vival after esophagectomy.10,12,20 In the present study, we
evaluated the percentage of preoperative weight loss,
rather than the BMI, because patients with esophageal
cancer and a high BMI are often malnourished owing to
severeweight loss.11 Additionally, weight loss, evenwithout
taking the BMI into account, can be a good indicator of
disease-related malnutrition.13,21 The>10% weight loss
cutoff was determined from studies in which weight loss
of 10% was not associated with an increased incidence
of postoperative complications21 but>10%was considered
to represent a severe nutritional risk.13 This is in contrast to
the findings of the present study, inwhichwe did not observe
an increased risk of complications after surgery. This could
have been because most studies have investigated major
abdominal surgery, including amix of oncologic operations,
and our study focused on patients with esophageal cancer.
In conclusion, patients with esophageal cancer who expe-
rience weight loss of>10% in the 3 months before diag-
nosis had no increased risk of postoperative complications
or longer hospital stay. However, they had increased 5-
year overall mortality after surgery. These results highlight
the need for studies to test whether improving the nutri-
tional status in malnourished patients with esophageal can-
cer before esophagectomy is beneficial from a prognostic
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